Galapagos NV
(NASDAQ : GLPG)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
REGNRegeneron Pharmaceuticals, Inc. -1.79%556.922.7%$639.83m
GILDGilead Sciences, Inc. -0.15%58.641.0%$576.83m
AMGNAmgen, Inc. 0.99%218.531.3%$572.65m
VRTXVertex Pharmaceuticals, Inc. -0.24%207.851.9%$532.91m
MRNAModerna, Inc. 8.73%71.480.0%$451.78m
ILMNIllumina, Inc. 2.08%316.143.5%$405.51m
EXASEXACT Sciences Corp. -5.46%120.5620.7%$281.36m
ALXNAlexion Pharmaceuticals, Inc. 3.25%118.582.0%$268.25m
NVAXNovavax, Inc. 7.73%87.6296.5%$256.80m
BIIBBiogen, Inc. 1.02%246.751.7%$253.65m
BNTXBioNTech SE 9.61%84.990.0%$217.19m
SRRKScholar Rock Holding Corp. -5.71%40.950.0%$164.99m
SGENSeagen Inc. -1.10%192.726.0%$143.37m
SRNESorrento Therapeutics, Inc. 2.90%7.301.4%$139.52m
CRSPCRISPR Therapeutics AG 1.99%96.590.6%$125.83m

Company Profile

Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. It operates through the Research & Development and Fee-for-Services segment. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.